HIT Consultant August 23, 2024
Syed Hamza Sohail

What You Should Know:

Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.

Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant retention.

Falfurrias Capital Partners Invests in Jumo Health to Enhance Clinical Trial Engagement and Diversity

Falfurrias Capital Partners has announced an investment in Jumo Health, aiming to address critical challenges in clinical trials, such as low enrollment, high dropout rates, and the lack of diverse representation. This strategic investment will bring new resources and expertise to Jumo Health, enhancing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Investments, Trends
FDA approves clinical trials for pig organ transplants
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success

Share This Article